Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LASTACAFT Duration in Acute Allergic Conjunctivitis
NCT01470118Phase 4Completed
- Sponsor
- Allergan
- Start
- Oct 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alcaftadine in allergic conjunctivitis (AC), sponsored by Allergan. Started Oct 2011; status: completed.
02
Drugs
alcaftadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01470118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470118.